Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
344.00
Change Change %
-14.15 -3.95%

Updated:15 Jul, 2019, 15:56 PM IST

BSE
344.65
Change Change %
-9.40 -2.65%

Updated:15 Jul, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Motilal Oswal
N/A
17-01-2018 Buy 547.65 651.00
N/A
Closed Long (1Y)
17-01-2019

Motilal Oswal Recommends 'Buy' On Laurus Labs



According to Motilal Oswal, in addition to strong base business of API manufacturing under antiretrovirals and Hepatitis C category, Laurus Labs is forward integrating to formulations for regulated markets. The company is also forward integrating in ARVs (antiretrovirals) for further improvement in profitability, the brokerage adds. 

Top